Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for publishing professionals · Wednesday, September 28, 2022 · 593,285,794 Articles · 3+ Million Readers

Global Hemodynamic Monitoring Market valued at $1.04 billion (2021), is set to witness a decent growth of 6% by 2026 – Increasing Occurrence of Cardiovascular, COPD & Respiratory Diseases

Medi-Tech Insights: Increasing prevalence of cardiovascular, COPD and respiratory diseases; development of next-generation non-invasive and minimally-invasive systems; and rapid growth in the surgical procedures are some of the key factors driving the global hemodynamic monitoring market.

/EIN News/ -- BRUSSELS, BELGIUM, Aug. 08, 2022 (GLOBE NEWSWIRE) --


Uncontrolled perturbations in circulatory function during surgery can lead to tissue hypoxia, resulting in perioperative morbidity and mortality. Hemodynamic monitoring provides information about the adequacy of a patient's circulation, perfusion, and oxygenation of the tissues and organ systems delivering safe anesthetic care.

Technological Advancements in Hemodynamic Monitoring Systems to fuel its Market Demand

Continuous advances in critical patient care have enabled to develop efficient hemodynamic monitoring systems featuring non-invasive technology and expanded parameters such as continuous BP measurements, measurement of cardiac output by pulse contour method, among others. Major market players are continuously focusing on investing in research activities for new product developments and expanding their geographic reach to strengthen their position in the hemodynamic monitoring market. Some of the technological advancements are listed below:

  • In July 2022, Retia Medical received Series B funding of $15 million led by Fresenius Medical Care Ventures to expand its commercial team and accelerate the development and commercialization of its Argos Hemodynamic Monitor.
  • In February 2022, Caretaker Medical received the US Food and Drug Administration (FDA) clearance to add four new parameters on its next-generation VitalStream wireless ‘beat-by-beat’ blood pressure and hemodynamic monitoring platform, to include stroke volume, cardiac output, left ventricular ejection time, and heart rate variability.
  • In March 2021, Philips introduced its interventional hemodynamic system featuring a patient monitor- IntelliVue X3 to provide advanced hemodynamic (blood flow) measurements and improve patient focus during image-guided procedures.
  • In October 2020, Getinge launched NICCI, an innovative advanced hemodynamic monitoring solution that provides continuous and non-invasive hemodynamic insights reducing the risk of severe complications in patients with low blood pressure.

Growing prevalence of cardiovascular diseases to boost adoption of Hemodynamic Monitoring Market

Advanced hemodynamic monitoring methods have the ability to enhance the monitoring of cardiac patients during post-operative care and anaesthesia providing precise and repeatable measurements to detect hemodynamic abnormalities and their causes. Cardiovascular diseases are one of the leading causes of death across the world. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the group of heart and blood vessel disorders known as CVDs.

  • According to WHO, 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year.
  • As per CDC,
    • 659,000 people in the US die from heart disease every year; heart diseases costs $363 billion each year in the US which includes cost of medicines and healthcare services.
    • Coronary heart disease alone killed 360,900 people in 2019 in the US and over 18.2 million adults suffering from coronary artery disease live in USA.
    • 805,000 people suffer from heart attack in the US every year of which 605,000 are a first heart attack while 200,000 happen to people already had a heart attack.
  • According to European Heart Network, CVDs account for over 3.9 million deaths every year in the European region, out of which over 1.8 million deaths occur in the European Union (EU).

Furthermore, rising geriatric population prone to heart defects due to progressive deterioration in the structure and function of the heart, largely contributes to the high burden of CVDs; thereby triggering the increased adoption of hemodynamic monitoring systems.

Competitive Landscape Analysis: Hemodynamic Monitoring Market

The hemodynamic monitoring market is marked by the presence of key market players such as Edwards Lifesciences Corporation (US); Getinge AB (Sweden); LiDCO Group (UK); Koninklijke Philips N.V. (Netherlands); ICU Medical (US); and others.

Get Detailed Research Insights on Hemodynamic Monitoring Market Report with TOC @

About Medi-Tech Insights:

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact Us:

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79

Primary Logo

Powered by EIN News

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release